From: Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk
SNP | Clinical Index | Genotype | Number in cases | Quantity in blood (mean ± SD) | p |
---|---|---|---|---|---|
rs7307242 | CEA (ng/ml) | AA | 7 | 14.94 ± 3.97 | 0.021* |
AT | 69 | 11.56 ± 3.55 | |||
TT | 229 | 12.78 ± 4.01 | |||
AFP (ng/ml) | AA | 7 | 19.55 ± 21.16 | < 0.001* | |
AT | 69 | 9.23 ± 3.82 | |||
TT | 227 | 9.61 ± 4.23 | |||
rs75750647 | CA125 (U/ml) | AA | 35 | 46.51 ± 131.23 | 0.032* |
AG | 129 | 24.09 ± 44.88 | |||
GG | 135 | 18.6 ± 24.39 | |||
CA199 (U/ml) | AA | 31 | 46.19 ± 163.92 | 0.033* | |
AG | 124 | 15.9 ± 14.45 | |||
GG | 130 | 20.32 ± 28.95 | |||
rs11610368 | HE4 (pg/ml) | AA | 3 | 295.38 ± 390.97 | 0.010* |
AG | 65 | 90.37 ± 99.74 | |||
GG | 233 | 91.49 ± 113.83 |